HRR Prevalence in LatAm PROSPECT Study

Trial Identifier: D081LR00003
Sponsor: AstraZeneca
NCTID:: NCT04962880
Start Date: April 2021
Primary Completion Date: April 2022
Study Completion Date: April 2022
Condition: Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Argentina Ciudad Autónoma de Buenos Aires, Argentina
Argentina Rosario, Argentina
Brazil Porto Alegre, Brazil
Brazil Rio de Janeiro, Brazil
Brazil São Paulo, Brazil
Colombia Bogotá, Colombia
Costa Rica San José, Costa Rica
Mexico Mexico City, Mexico
Mexico, Mexico DF Mexico City, Mexico DF, Mexico
Panama Panamá, Panama
Peru Lima, Peru